Could injecting immunotherapy into lymph nodes boost cervical cancer treatment?
NCT ID NCT07653503
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial explores whether injecting the immunotherapy drug nivolumab directly into lymph nodes before standard surgery is feasible and safe for people with cervical cancer. The study involves 12 participants and aims to see if this targeted approach can shrink tumors and improve surgical outcomes. If successful, it may pave the way for larger studies to confirm benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nivolumab
What this could lead to
If this approach works, it could offer a new way to treat cervical cancer by targeting the immune system directly at the lymph nodes, potentially improving surgical outcomes.
What could go wrong
This is a very early phase 1 trial with only 12 participants, so results may not apply broadly. The treatment could cause side effects or fail to improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medical Centre Groningen
RECRUITINGGroningen, 9700 RB, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••